Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer
Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer
Active, not recruiting · NCT04922307 · Registry updated 2025-11-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, kidney cancer, kidney disorder, neoplasm, urinary system disorder | Active, not recruiting | Not applicable | 2025-11-12 | NCT04922307 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Vanderbilt University Medical Center | 299 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| H. Lee Moffitt Cancer Center | Tampa | United States | 13 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |
| Winship Cancer Institute At Emory University | Atlanta | United States | 10 |